BSECompany Update4d ago · 5 Nov 2026, 04:29 pm
Intimation regarding non-applicability of regulation 23(9)
Brawn Biotech Ltd · 530207
✦ AI SummaryRegulatory
Brawn Biotech Ltd has submitted an undertaking to the BSE, stating that the company is not required to file related party transactions as per Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, due to its paid-up share capital and net worth not exceeding Rs. 10 crore and Rs. 25 crore, respectively, as on March 31, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brawn Biotech Ltd - 530207 - Intimation Regarding Non-Applicability Of Regulation 23(9)
Attachments (1)
📄pdf
Download →
5364a4f9-3290-4d99-b5f1-8e715de46a44.pdf
View document text
BRAWN BIOTECH LTD.
Date: 5" November, 2026
The Manager
Listing Compliances,
BSE Limited, Floor-25, PJ Towers,
Dalal Street, Mumbai-400001
Scrip Code: 530207
Sub: Submission of Undertaking for non-applicability for filling of related party transactions as
required under Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement)
Regulations, 2015
Dear Sir/Madam,
With reference to the captioned subject, we would like to apprise your good self that our company had
a Paid-up Share Capital of Rs. 3 Crores and a Net Worth of Rs. 4.32 Crores (Appx.) as on March 31,
2026.
The requirement of filling of Related Party Transactions is not applicable on the Company for year
ended March 31, 2026 as per Regulation 15(2) of SEBI (Listing Obligation and Disclosure
Requirement) Regulations, 2015, as the paid-up equity share capital not exceeding rupees Ten crore and
net worth not exceeding rupees twenty-five crore, as on the last day of the previous financial year.
Further Paid-up Share Capital and Net Worth of the Company remained below the specified threshold
of Rs. 10 Crore and Rs. 25 Crore since the period of last three consecutive financial years.
Thus, our Company falls under the above-mentioned criteria and is not required to comply with the
above-mentioned provisions for the quarter ended September 2026.
We request you to kindly take the above information on record.
Priyanka Sharma
Company Secretary & Compliance Officer
Membership No. A50385
‘ CIN NO.: L74899DL1985PLC022468 0.f on betten life
Regd. Office : C-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331
Email: solution@brawnbiotech.com
Works : Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA
BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in